Reducing Frailty for Older Cancer Survivors Using Supplements
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to to obtain preliminary data on the effects of twelve weeks oral
supplementation of Epigallocatechin-3-gallate (EGCG) on frailty and inflammation in older
survivors of colon cancer